The LR Group was founded in 1985 by Ami Lustig and Roy Ben Yami. The firm focuses on providing investment, financing, restructuring, and development of businesses involved with rural areas revitalisation, large-scale agricultural integration projects, water management, renewable energy and power, housing and construction, telecommunications, hospitals and clinics, and education and training. Among its notable long-term projects are 9 Mile Vegetable Farm in Papua New GuineaPapua New Guinea, Sunshine Hospital in China, Rural Water Supply in Sri Lanka's North West Province, N’sele Presidential Farm in the Democratic Republic of Congo, and Adama Aldeia Nova in Angola.
LR Group is an Israel-based investment firm that offers financing, consultation, and management services for medium to large scale companies specialising in agriculture, water, energy and power, telecom, health, and construction.
The LR Group was founded in 1985 by Ami Lustig and Roy Ben Yami. The firm focuses on providing investment, financing, restructuring, and development of businesses involved with rural areas revitalisation, large-scale agricultural integration projects, water management, renewable energy and power, housing and construction, telecommunications, hospitals and clinics, and education and training. Among its notable long-term projects are 9 Mile Vegetable Farm in Papua New Guinea, Sunshine Hospital in China, Rural Water Supply in Sri Lanka's North West Province, N’sele Presidential Farm in the Democratic Republic of Congo, and Adama Aldeia Nova in Angola.
Anthem Venture Partners is a venture capital firm that offers private equity investments in early-stage Series A technology companies.
Anthem Venture Partners is a Santa Monica-based venture capital firm that specializes in early-stage investments. It was founded in 2003 by William Woodward. The company focuses on investing in early-stage Series A and Series B firms based in Southern California within the mobile, semiconductor, software and internet sectors.
Anthem Venture Partners's typical deal size is an initial investment between $1,000,000 and $5,000,000 with reserve for follow-on investments. Among the companies included in their portfolio are Interset, Entropic Communications, Cognet Fibre Optic Network, and Dot Wireless.
Company
Novak Biddle Venture Partners provides early-stage equity financing and assistance to the management of information technology companies principally located in the Mid-Atlantic region.
Novak Biddle Venture Partners was established in 1997 by E. Rogers Novak, Jr., and A.G.W. Biddle, III to provide equity financing and assistance to the management of startup information technology companies chiefly located in the Mid-Atlantic region.
Novak Biddle focuses its investments on information technology companies in the communications, consumer and internet, education, security, services, and software sectors. The company has over $580 million under management and is backed by a number of limited partners.
Novak Biddle Venture Partners is a member of the National Venture Capital Association.
Company
Oxford Bioscience Partners is an early-stage venture capital investment firm that invests in life sciences, technology, energy, and healthcare industries.
Oxford Bioscience Partners is an early-stage venture capital investment firm that invests in life sciences and healthcare sectors with a focus on technology, medical devices, instruments and systems, and therapeutics companies. It was established in 1992 by Cornelius T. Ryan and Edmund M. Olivier.
Oxford Biosciences Partners has approximately $1B of committed capital under management. It has invested in over 140 life science companies worldwide, including Yolia Health, CardioFocus, Affinium Pharmaceuticals, Mitralign, and Seahorse Bioscience.
Seed and early stage venture capital firm in the Midwest.
Venture Investors, LLC is an asset management and private equity firm in the Midwest that provides seed, early-stage, and late-stage funding round for healthcare and technology companies.
Venture Investors Management LLC is a venture capital firm founded in 1982 by John Neis and Roger Ganser. Headquartered in the Midwest, the company provides seed, early-stage, and late-stage funding round for healthcare startups with expertise in medical devices, therapeutics, diagnostics, and healthcare IT systems.
Venture Investors have $275 million in assets under management. Some of the companies included in Venture Investors' portfolio are Invenra, ViaLase, HistoSonics, and Eximis Surgical, Inc.
Essex Woodlands Health Ventures is a growth equity and venture capital firm investing in companies in the pharmaceutical, biotechnology, medical device, services, and information technology sectors.
Essex Woodlands Health Ventures is a growth equity and venture capital firm headquartered in Chicago, Illinois. The company was founded in 1985 by Jim Currie and Marty Sutter.
Since its inception, the Partnership has raised seven additional funds with nearly $2.5 billion under management. Essex Woodlands partners with revenue-generating companies in the pharmaceutical, biotechnology, medical device, services, and information technology sectors such as Bioventus, Encore Dermatology, Suneva Medical, Metabolon, and TissueTech.
Essex Woodlands has offices in New York, Palo Alto, Houston, and London.
Company
Skyline Ventures is a venture capital firm that specialises in investing in outstanding product-focused healthcare companies.
Skyline Ventures is a venture capital firm that specialises in investing in outstanding product-focused healthcare companies with expertise include small molecule and protein therapeutics; medical devices; diagnostics; and technologies that facilitate drug discovery and life science research. The company was founded in 1997 by a group of medical professionals led by John Freund and Eric M. Gordon. Its headquarters is located in Palo Alto, California.
Skyline Ventures has approximately $800 million under management. It targets to invest $15-35 million per portfolio company over the life of the company. Among the companies included in Skyline Ventures' portfolio are AcelRx Pharmaceuticals, Avidia, Crescendo Bioscience, and NovaCardia.
The Aurora Funds is a venture capital firm that provides capital, connections and strategic guidance to entrepreneurs with early-stage healthcare and information technology companies.
The Aurora Funds is a venture capital firm that provides capital, connections and strategic guidance to entrepreneurs with early-stage healthcare and information technology companies. Founded in 1994 by Jeff Clark and Scott Albert, the firm manages over $234 million in five venture funds. Among the companies that Aurora has invested in are Agility Healthcare Solutions, Argos Therapeutics, CardioFocus, Cardioxyl Pharmaceutical, Centice, Data Flux, and Digital Smiths.
Aurora is located in the Research Triangle Park (RTP) area of North Carolina. The company is no longer making any new investments.
Signal Peak is a Salt Lake City basedCity-based venture capital firm investing in early-stage technology companies across the United States.
Signal Peak is a private equity and venture capital firm with more than $550 million of committed capital under management. Founded in 2011 by Ron Heinz and Scott Petty, the firm focuses its investments on companies in the information technology sector with expertise in internet, SaaS, enterprise software, communications, security, and mobile computing.
Signal Peak has funded more than 30 investments, including WildWorks, Verismic Software, Teal, PactSafe, InfusionSoft, and Aspen Avionics. Signal Peak is headquartered in Salt Lake City, Utah.
Brainchild Holdings was founded in 2009 by entrepreneur Kal Vepuri. The company is based in Newtown, Pennsylvania.
Brainchild Holdings has independently funded over 135 companies and has pre-seeded or seeded healthcare, technology and consumer products companies including Hero, Docker, Oscar Health, Gusto, Forward, Harry's, Warby Parker, Dataminr, Blockstack, Astranis, ClassPass, Seatgeek, Allbirds, Sweetgreen, Quartet Health, Cricket Health, Atrium, Quip, Mirror, Science Exchange, DuckDuckGo, Drift Energy, Arcadia Power, The Wing, Heyday, WayUp, Outdoor Voices, Reformation, Immunomic Therapeutics, SmithRx, MakerBot, SmartThings and Artsy. The firm also holds Series A and/or growth stage positions in Uber, Pinterest, Peloton, Clover Health, Color Genomics, Zillow and XPO Logistics.
Easton Capital is a New York-based investment group with a sector focus in life sciences and healthcare.
Easton Capital Investment Group manages approximately $200 million on behalf of a number of significant institutional investors in its three funds, Easton Capital Partners, L.P., Easton Hunt Capital Partners, L.P. and Easton Hunt New York LP.
Founded in 1999 by John H. Friedman, the firm makes investments ranging in size from $2 million to $7.5 million. It seeks to invest in companies operating in the healthcare, information technology, diagnostic, therapeutic and biotechnology sectors.
Easton Capital has invested in more than 50 companies since its establishment, including Acorda Therapeutics, Somnus Medical Technologies, Protez Pharmaceuticals, Tigertext, Medikly, and Parexel
Easton Capital has offices in New York and Florida.
ProQuest Investments is a venture capital firm seeking to invest in seed to late-stage healthcare companies.
ProQuest Investments was founded in 1998 by seasoned healthcare executive, Jay Moorin. The company has over $900 million under management.
ProQuest Investments provides seed to late-stage funding for healthcare companies with expertise in therapeutics, drug discovery technologies, and molecular analysis. The firm has backed over 25 companies since its inception including
Achillion Pharmaceuticals, ReVision Optics, Mevion Medical Systems, Rigel Pharmaceuticals, and SomaLogic.
Cardinal Partners invests in healthcare technology-enabled services and life sciences companies.
Cardinal Partners is a venture capital company specialising in early/growth-stage financing rounds for entrepreneurs operating in the healthcare and life sciences sector.
Cardinal Partners is a Princeton-based venture capital company founded in 1996 by John Clarke, Thomas McKinley, and Kent Marquardt. As early/growth-stage investors, Cardinal Partners works with scientists, consultants, and entrepreneurs in the field of life sciences, technology-enabled services, and healthcare IT.
Cardinal Partners' most recent investment was on Apr 30, 2019, when Vividion Therapeutics raised $82M.
Caixa Capital Risc invests companies focused on corporate software, communications equipment, Internet, mobility, therapeutic treatments, medicines, health services, new materials, sustainability, and industrial technology.
Caixa Capital Risc is the venture capital division of la Caixa Foundation focused on investing in the early stages of innovative startups.
Caixa Capital Risc is the Barcelona-based venture capital arm of CriteriaCaixa that provides equity and convertible loans to innovative companies in their early stages. The company also offers support during the A and B Series rounds, if necessary.
Founded in 2004, Caixa Capital Risc manages a capital of 195 million euros and invests mainly in Spanish companies in the information technology, communication equipment, healthcare, life sciences, and industrial technology sector.
Marcelino Armenter is the CEO for Caixa Capital Risc.
First Capital Group is a venture capital firm that invests in a diversified portfolio of middle-market companies with demonstrated growth potential in the United States.
First Capital Group was founded in 1984 in Dallas, Texas by Gary Graham and Jeffrey Blanchard. The company caters to middle-market companies in Texas and the Southwest. Sectors of interest include Information Technology, Life Sciences, Communications, Manufacturing, Services, and Distribution.
First Capital Group offers services that are focused on business planning, capital formation and budgeting, merger and acquisition evaluation, and execution of exit strategies.
ICICI Lombard General Insurance is a general insurance company in India engaged in general insurance, reinsurance, insurance claims management, and investment management.
ICICI Lombard General Insurance Company was established in 2001 as a joint venture between ICICI Bank, one of India's largest banks, and Fairfax Financial Holdings Limited, a financial services company in Toronto, Canada.
Headquartered in Mumbai, India, the company offers policy insurance and renewal through its intermediaries and website. It also markets assurance products such as Health Insurance, Travel Insurance, Home Insurance, Marine Insurance, Crop/Weather Insurance, and Liability Insurance.
Bhargav Dasgupta is the Managing Director and CEO of ICICI Lombard General Insurance Company.
NEA-IndoUS Ventures Capital operates as a venture capital firm that provides early to mid-stage funding to businesses in India.
NEA-IndoUS Ventures Capital is an India-focused venture fund founded on December 8, 2006 by Vinod Dham and serial entrepreneur Vani Kola in collaboration with US venture capital firm New Enterprise Associates (NEA).
The firm focuses its investments on early and mid-stage companies in mobile services, digital media and content, telecom and enterprise, business process outsourcing (BPO), software products and services, engineering design, and healthcare sectors. Among these are Snapdeal and Myntra which was later acquired by FlipKart.
Plutus Capital LLC is a venture capital and private equity firm investing in Software, Information Technology, and Business Process Management companies.
Plutus Capital, LLC is a privately-held venture capital founded in April 2017 by Hari Murthy and Hitesh Zaveri. Plutus Capital offers its services to entrepreneurs and shareholders in the Information Technology, Enterprise Software, and Business Process Management sector by providing consultation, strategic management, business restructuring, and growth-stage investments.
Plutus Capital's headquarters is located in Boston, Massachusetts. They also have offices in Silicon Valley, California, and Mumbai, India.
On May 8, 2018, EuroUS Ventures helped to raise $13.75 million in Series B funding for Lyncean Technologies, Inc.